Clinical Trial

Guangdong Endometriosis Retrospective Clinical Cohort

Completed
View on ClinicalTrials.gov →
Summary
This retrospective cohort study evaluates the association between postoperative hormonal treatment and recurrence of ovarian endometriosis in women undergoing surgery for ovarian endometrioma. The study includes patients treated at a single center who initiated one postoperative hormonal regimen after surgery. The main objective is to compare the risk of recurrence among women receiving combined oral contraceptives, gonadotropin-releasing hormone agonists, dienogest, or dydrogesterone. Recurrence is assessed during follow-up based on postoperative clinical and ultrasound findings. The results may help clarify the comparative effectiveness of commonly used postoperative hormonal strategies for reducing recurrence after surgery for ovarian endometrioma.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-04-02; most recent amendment 2026-07-06.
Trial Details
NCT Number NCT07519213
Lead Sponsor Guangdong Women and Children Hospital
Conditions Ovarian Endometrioma, Endometriosis
Enrollment 1,121 participants
Start Date 2025-09-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-08